HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Patient Involvement in Research: Ethical considerations and patient advocacy in research.

Patient involvement in cancer research is essential for improving outcomes and ensuring ethical considerations are met. Involving patients in clinical trials helps to align research goals with real-world needs, enhancing the relevance of the findings. Ethical concerns, such as informed consent, confidentiality, and the use of patient data, must be carefully managed to protect participants. Patient advocacy groups play a significant role in representing the interests of those affected by cancer, ensuring that trials are accessible and focused on meaningful outcomes. This collaborative approach fosters trust and ensures that patients' voices are integral to shaping research agendas, ultimately leading to better and more personalized treatments.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp